Announced Sat, 30 May · 16:24 IST

Intimation of re-appointment of Internal Auditor for the financial year 2026-27.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-7.1%1-day move
₹56.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-7.1-2.9+5.4+17.0+21.1+36.8+42.2+39.3
Up moveDown movePending
AI summary

Novelix Pharmaceuticals Ltd has announced the re-appointment of M/s V R P S & Co., Chartered Accountants as Internal Auditors for the financial year 2026-27. The Board of Directors approved this re-appointment at their meeting held on May 29, 2026. The appointment is made to comply with the Companies Act 2013 and SEBI Listing Regulations. The auditor has confirmed that it is not related to any Directors, Key Managerial Personnel, or their relatives. The Board meeting was held from 05:00 PM to 06:30 PM on May 29, 2026.

Likely market impact

This is a routine compliance filing confirming the continuation of the company's internal audit function. It indicates normal corporate governance practices and has no direct impact on the stock price or shareholder value.